Aadi Bioscience, Inc.

NasdaqCM AADI

Aadi Bioscience, Inc. Dividend Yield on January 14, 2025: 0.00%

Aadi Bioscience, Inc. Dividend Yield is 0.00% on January 14, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Aadi Bioscience, Inc. 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
Aadi Bioscience, Inc. 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
Aadi Bioscience, Inc. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: AADI

Aadi Bioscience, Inc.

CEO	Mr. David J. Lennon Ph.D.
IPO Date	Feb. 16, 2018
Location	United States
Headquarters	17383 Sunset Boulevard
Employees	53
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Key trends

Past 5 years